|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| A61P 35/00 | (2006.01) | ||
| A61K 38/17 | (2006.01) | ||
| C07K 16/28 | (2006.01) |
| (11) | Number of the document | 2100618 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09075102.5 |
| Date of filing the European patent application | 2006-06-19 | |
| (97) | Date of publication of the European application | 2009-09-16 |
| (45) | Date of publication and mention of the grant of the patent | 2014-02-12 |
| (46) | Date of publication of the claims translation | 2014-06-25 |
| (30) | Number | Date | Country code |
| 691920 P | 2005-06-17 | US |
| (72) |
Loizos, Nick, US
Dolloff, Nathan Graeme, US
Fatatis, Alessandro, US
|
| (73) |
ImClone LLC,
450 East 29th Street, 12th Floor, New York, NY 10016,
US
Philadelphia Health and Education Corporation d/b/a Drexel University College of Medicine, 245 North 15th Street, Philadelphia, PA 19102, US |
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | Antikūnai prieš PDGFRalfa, skirti naudoti metastazinio kaulų vėžio gydymui |
| An anti-PDGFRalpha antibody for use in the treatment of metastatic bone cancer |
| Payment date | Validity (years) | Amount | |
| 2019-06-17 | 14 | 289.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2020-06-19 |